The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| RNLX | +47.19% | -98.23% | -55.34% | -99% |
| S&P | +13.19% | +87.83% | +13.42% | +109% |
Renalytix Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.
You can pick up small pieces of these great businesses for next to nothing.
Analyst estimates suggest these stocks can deliver eye-popping gains once the rest of the stock market views them in the same light.
| Q4 2024 | YOY Change | |
|---|---|---|
| Revenue | $0.72M | 1.0% |
| Gross Profit | $0.39M | 70.7% |
| Gross Margin | 54.60% | 22.3% |
| Market Cap | $34.78M | 78.5% |
| Net Income | -$3.85M | 55.1% |
| EBITDA | -$4.35M | 47.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2024 | YOY Change | |
|---|---|---|
| Net Cash | $9.21M | 63.9% |
| Accounts Receivable | $0.51M | -62.8% |
| Inventory | 0.4 | 0.0% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Long Term Debt | $8.21M | 54.5% |
| Short Term Debt | $0.00M | -100.0% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Return On Assets | -206.39% | -6.0% |
| Return On Invested Capital | 81.36% | 288.9% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$9.97M | -25.9% |
| Operating Free Cash Flow | -$9.97M | -25.9% |
| Metric | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -5.40 | -1.25 | -2.05 | -1.54 | -87.45% |
| Price to Sales | 18.87 | 7.78 | 4.67 | 14.67 | 87.32% |
| Price to Tangible Book Value | -5.40 | -1.25 | -2.05 | -1.43 | -88.34% |
| Enterprise Value to EBITDA | -7.70 | -3.96 | -4.52 | -7.67 | 191.50% |
| Return on Equity | -9044.0% | -1074.5% | - | ||
| Total Debt | $9.42M | $8.54M | $8.25M | $8.21M | -3.29% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
